Description

IVERNORM 1% CREAM 20GM

Indications

IVERNORM 1% Cream is primarily indicated for the treatment of various parasitic infections, particularly those caused by ectoparasites such as scabies and lice. The active ingredient, ivermectin, is effective in eliminating these parasites by disrupting their nervous system and muscle function. This cream formulation provides a convenient and localized treatment option for patients suffering from these conditions.

Mechanism of Action

The mechanism of action of ivermectin involves its binding to specific channels in the parasite’s nerve and muscle cells. Ivermectin enhances the permeability of the cell membranes to chloride ions, leading to hyperpolarization of the cells. This hyperpolarization results in paralysis and death of the parasites. Additionally, ivermectin may inhibit the reproduction of certain parasites, further aiding in the eradication of the infestation.

Pharmacological Properties

IVERNORM 1% Cream contains ivermectin as its active ingredient, which is a broad-spectrum antiparasitic agent. Ivermectin is derived from the fermentation products of the soil bacterium Streptomyces avermitilis. The cream formulation allows for topical application, which is particularly beneficial for localized infestations. Pharmacokinetically, ivermectin has a low systemic absorption when applied topically, minimizing potential systemic side effects while effectively targeting the intended site of action.

Contraindications

IVERNORM 1% Cream is contraindicated in individuals with a known hypersensitivity to ivermectin or any other components of the cream. It should not be used in patients with a history of severe allergic reactions to similar medications. Additionally, it is not recommended for use in children under the age of 5 years or in pregnant and lactating women without medical advice, as the safety of ivermectin in these populations has not been fully established.

Side Effects

Common side effects associated with the use of IVERNORM 1% Cream may include local skin reactions such as itching, redness, and irritation at the application site. In rare cases, systemic side effects may occur, including headache, dizziness, and gastrointestinal disturbances. Patients should be advised to report any unusual or severe reactions to their healthcare provider promptly. It is essential to monitor for signs of allergic reactions, such as rash, swelling, or difficulty breathing, which may require immediate medical attention.

Dosage and Administration

IVERNORM 1% Cream should be applied topically to the affected areas of the skin. The recommended dosage is to apply a thin layer of the cream to the affected area once daily for a specified duration, usually 1 to 2 weeks, depending on the severity of the infestation. It is crucial to follow the healthcare provider’s instructions regarding the duration of treatment and to avoid applying the cream to broken or inflamed skin. Patients should wash their hands thoroughly after applying the cream to prevent accidental transfer to other areas or individuals.

Interactions

While IVERNORM 1% Cream is primarily used topically, it is essential to consider potential drug interactions when used in conjunction with other medications. There is limited systemic absorption of ivermectin from the cream; however, caution should be exercised when using it alongside other topical medications that may cause skin irritation or enhance absorption. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter products and supplements, to avoid any potential interactions.

Precautions

Before using IVERNORM 1% Cream, patients should be evaluated for any pre-existing skin conditions that may affect treatment. It is essential to avoid contact with the eyes and mucous membranes, as ivermectin can cause irritation. Patients should also be advised to refrain from using occlusive dressings over the treated area unless directed by a healthcare professional. Additionally, caution should be exercised in patients with liver impairment, as this may affect the metabolism of ivermectin.

Clinical Studies

Several clinical studies have demonstrated the efficacy of ivermectin in treating scabies and lice infestations. In a randomized controlled trial, patients treated with ivermectin showed a significant reduction in parasite counts and improvement in symptoms compared to those receiving placebo. Another study highlighted the effectiveness of topical ivermectin in managing resistant cases of scabies, showcasing its role as a valuable treatment option. These studies support the use of IVERNORM 1% Cream as a safe and effective topical treatment for ectoparasitic infections.

Conclusion

IVERNORM 1% Cream represents a significant advancement in the treatment of ectoparasitic infections, offering a targeted and effective solution for patients suffering from scabies and lice. With its well-established mechanism of action and favorable safety profile, this topical formulation provides an essential tool for healthcare providers in managing these common conditions. Patients should be educated about the proper use of the cream and advised to report any adverse effects or concerns to their healthcare provider.